Product Information

TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB is a generic product labeled by BluePoint Laboratories, priced at $0.0983 per EA under NDC 68001032700. Its NADAC has been published 425 times since Aug 2, 2017.

FDA first approved this application on Apr 17, 1988. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB

Triamterene and Hydrochlorothiazide
$0.0983per EA

Strength

25; 37.5 mg/1; mg/1

NDC

68001032700

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA071251

FDA Approved

4/17/1988

TE Code

AB

On Market Since

4/30/2017

Pharmacological Classes

Decreased Renal K+ Excretion
Increased Diuresis
Increased Diuresis
Potassium-sparing Diuretic
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has been published 425 times since Aug 2, 2017, and over the history we have for it it has declined 17.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0983 per EA
All-time high$0.1409 (Aug 15, 2018)
All-time low$0.0721 (Nov 20, 2024)
52-week high$0.0983
52-week low$0.0915
Median price$0.0983
Average price$0.1036
Largest weekly change-29.0% (Nov 20, 2024)
Weeks tracked425
Tracking sinceAug 2, 2017

Price History

1W

+0.3%

1M

+0.3%

3M

+0.4%

6M

+5.7%

1Y

+1.7%

3Y

+5.4%

5Y

-3.9%

All

-17.4%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB, manufactured by BluePoint Laboratories, is $0.0983 per EA (NDC 68001032700), effective Aug 19, 2026.

How has the price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB changed over time?

Over the history we have for it, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has declined 17.4%. It has been tracked across 425 weekly CMS publications since Aug 2, 2017.

What are the highest and lowest recorded NADAC prices for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?

Since Aug 2, 2017, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has ranged from a low of $0.0721 (Nov 20, 2024) to a high of $0.1409 (Aug 15, 2018), with a median of $0.0983 per EA.

Are there cheaper alternatives to TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB, is $0.0963 per EA — about 2% below TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB.

Who manufactures TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?

TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB (NDC 68001032700) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.